CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +151,505 | 151,505 | ||
| 2023-02-13 | Lehr Martin A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +287,544 | 287,544 | ||
| 2023-02-13 | Minai-Azary Jennifer Lynn Chief Financial Officer | Grant or award · Stock Option (right to buy) | +158,001 | 158,001 | ||
| 2023-02-13 | Lehr Martin A. Chief Executive Officer | Purchase | +5,606 | $0.87 | $5K | 153,878 |
| 2023-02-06 | Lehr Martin A. Chief Executive Officer | Purchase | +5,040 | $0.97 | $5K | 148,272 |
| 2023-01-30 | Lehr Martin A. Chief Executive Officer | Purchase | +7,027 | $0.70 | $5K | 143,232 |
| 2023-01-23 | Lehr Martin A. Chief Executive Officer | Purchase | +6,839 | $0.72 | $5K | 136,205 |
| 2023-01-17 | Lehr Martin A. Chief Executive Officer | Purchase | +6,783 | $0.74 | $5K | 129,366 |
| 2022-12-16 | Minai-Azary Jennifer Lynn Chief Financial Officer | Purchase | +25,000 | $0.74 | $19K | 40,000 |
| 2022-12-16 | Lehr Martin A. Chief Executive Officer | Purchase | +20,000 | $0.74 | $15K | 122,583 |
| 2022-12-09 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | +6,000 | $0.85 | $5K | 9,000 |
| 2022-08-19 | Lehr Martin A. Chief Executive Officer | Purchase | +13,000 | $1.85 | $24K | 102,583 |
| 2022-08-17 | Minai-Azary Jennifer Lynn Chief Financial Officer | Purchase | +15,000 | $1.80 | $27K | 15,000 |
| 2022-08-16 | Sahmoud Tarek Chief Medical Officer | Purchase | +10,000 | $1.95 | $20K | 10,000 |
| 2022-08-12 | Sahmoud Tarek Chief Medical Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-02 | West Linda Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-02 | Kantoff Philip W. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-02 | BERMAN RICHARD J Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-06-02 | Stacey Jennifer Evans Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Levit Alex C. Chief Legal Officer, Corp. Sec | Grant or award · Stock Option (right to buy) | +107,870 | 107,870 |
Page 3 of 5 · 85 trades